Resultados de la búsqueda

Garcia-Lunar I, Blanco I, Fernandez-Friera L, Prat-Gonzalez S, Jorda P, Sanchez J, Pereda D, Pujadas S, Rivas M, Sole-Gonzalez E, Vazquez J, Blazquez Z, Garcia-Picart J, Caravaca P, Escalera N, Garcia-Pavia P, Delgado J, Segovia-Cubero J, Fuster V, Roig E, Barbera JA, Ibanez B, Garcia-Alvarez A Design of the beta3-Adrenergic Agonist Treatment in Chronic Pulmonary Hypertension Secondary to Heart Failure Trial JACC Basic Transl Sci (2020) 51:317-327
Link to the full text in Repisalud

Bianco M, Careggio A, Destefanis P, Luciano A, Perrelli MG, Quadri G, Rossini R, Campo G, Vizzari G, D'Ascenzo F, Anselmino M, Biondi-Zoccai G, Ibanez B, Montagna L, Varbella F, Cerrato E P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients Eur Heart J Cardiovasc Pharmacother (2020) Jun 16 [Epub ahead of print]

Lorente-Ros A, Monteagudo Ruiz JM, Rincon LM, Ortega Perez R, Rivas S, Martinez-Moya R, Sanroman MA, Manzano L, Alonso GL, Ibanez B, Zamorano JL Myocardial injury determination improves risk stratification and predicts mortality in COVID-19 patients Cardiol J (2020) 27:489-496

Nuche J, Segura de la Cal T, Jimenez Lopez Guarch C, Lopez-Medrano F, Delgado CP, Ynsaurriaga FA, Delgado JF, Ibanez B, Oliver E, Subias PE Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension Diagnostics (2020) 10:E548
Link to the full text in Repisalud

Spaczynska M, Rocha SF, Oliver E Pharmacology of Pulmonary Arterial Hypertension: An Overview of Current and Emerging Therapies ACS Pharmacol Transl Sci (2020) 3:598-612
Link to the full text in Repisalud

Lee JM, Choi KH, Doh JH, Nam CW, Shin ES, Hoshino M, Murai T, Yonetsu T, Mejia-Renteria H, Kakuta T, Escaned J, Koo BK Long-Term Patient Prognostication by Coronary Flow Reserve and Index of Microcirculatory Resistance: International Registry of Comprehensive Physiologic Assessment Korean Circ J (2020) 50:e101

Cortes C, Johnson TW, Silber S, Buszman PP, Poerner TC, Lavarra F, Ibanez B, Kim Y, Mischke K, Jaguszewski M, Gutierrez-Chico JL ISCHEMIA trial: The long-awaited evidence to confirm our prejudices Cardiol J (2020) 27:336-341

Laveriano-Santos EP, Parilli-Moser I, Ramirez-Garza SL, Tresserra-Rimbau A, Storniolo CE, Ruiz-Leon AM, Estruch R, Bodega P, Miguel M, Cos-Gandoy A, Carral V, Santos-Beneit G, Fernandez-Alvira JM, Fernandez-Jimenez R, Fuster V, Lamuela-Raventos RM Polyphenols in Urine and Cardiovascular Risk Factors: A Cross-Sectional Analysis Reveals Gender Differences in Spanish Adolescents from the SI! Program Antioxidants (2020) 9:910
Link to the full text in Repisalud

Garcia-Lunar I, Pereda D, Ibanez B, Garcia-Alvarez A Neurohormonal Modulation as a Therapeutic Target in Pulmonary Hypertension Cells (2020) 9:2521

Fabris E, Hermanides R, Roolvink V, Ibanez B, Ottervanger JP, Pizarro G, van Royen N, Mateos-Rodriguez A, Dambrink JH, Albarran A, Fernandez-Aviles F, Botas J, Remkes W, Hernandez-Jaras V, Kedhi E, Zamorano J, Alfonso F, Garcia-Lledo A, van Leeuwen M, Nijveldt R, Postma S, Kolkman E, Gosselink M, de Smet B, Rasoul S, Lipsic E, Piek JJ, Fuster V, van 't Hof AW Beta-blocker effect on ST-segment: a prespecified analysis of the EARLY-BAMI randomised trial Open Heart (2020) 7:e001316